We studied the effects of Nω-nitro-L-arginine (L-NNA), a nonselective inhibitor of NO synthases, on the severity of type 1 diabetes mellitus induced by subcutaneous injection of 130 mg/kg alloxan in August rats with high activity of NO system and in Wistar rats. Five days after alloxan injection, hyperglycemia levels after overnight fasting in August and Wistar rats were 27.1±3.7 and 22.0±1.1 mmol/liter, respectively (p<0.03). The mortality over 15 days after alloxan injection in August rats was higher than in Wistar rats (36 and 26%, respectively). L-NNA normalized glucose levels in diabetics of both groups. It completely prevented mortality in August and reduced it to 13% in Wistar rats. Body weight loss and polydipsia after LNNA injection were also less pronounced in August rats. Plasma nitrite/nitrate concentrations in August rats were 32% higher than in Wistar rats, both in intact and diabetic rats. These data attest to an important role of NO in the pathogenesis of alloxan diabetes.
This is a preview of subscription content, log in via an institution to check access.
Similar content being viewed by others
References
V. Z. Lankin, V. I. Korchin, G. G. Konovalova, et al., Byull. Eksp. Biol. Med., 137, No. 1, 20–23 (2004).
N. Benjamin and P. Vallance, Lancet, 344, 960 (1994).
S. Cellek, P. N. Anderson, and N. A. Foxwell, Diabetes, 54, No. 1, 212–219 (2005).
A. Ceriello, L. Quagliaro, M. D’-Amico, et al., Ibid., 51, No. 4, 1076–1082 (2002).
M. J. Crespo, J. Zalacain, D. C. Dunbar, et al., J. Cardiovasc. Pharmacol. Ther., 13, No. 1, 64–71 (2008).
M. A. El-Missury, A. I. Othman, and M. A. Amer, J. Appl. Toxicol., 24, No. 2, 93–97 (2004).
E. Ho, G. Chen, and T. M. Bray, FASEB J., 13, No. 13, 1845–1854 (1999).
S. Lenzen, Diabetologia, 51, No. 2, 216–226 (2008).
A. Maree, G. Peer, A. Iaina, et al., Clin. Sci. (Lond.), 90, No. 5, 379–384 (1996).
M. L. McDaniel, J. A. Corbett, G. Kwon, and J. R. Hill, Adv. Exp. Med. Biol., 426, 313–319 (1997).
J. D. Mendez and R. De Haro Hernandez, Biomed. Pharmacother., 59, No. 6, 283–289 (2005).
U. Siebenlist, G. Franzoso, and K. Brown, Ann. Rev. Cell Biol., 10, 405–455 (1994).
A. Vasilijevic, B. Buzadzic, A. Korac, et al., J. Physiol., 5849, Pt. 3, 921–933 (2007).
I. C. West, Diabet. Med., 17, No. 3, 171–180 (2000).
G. Zhao, X. Zhang, C. J. Smith, et al., Am. J. Physiol., 277, No. 1, Pt. 2, H268–H278 (1999).
Author information
Authors and Affiliations
Corresponding author
Additional information
Translated from Byulleten’ Eksperimental’noi Biologii i Meditsiny, Vol. 154, No. 11, pp. 555-558, November, 2012
Rights and permissions
About this article
Cite this article
Belkina, L.M., Smirnova, E.A., Terekhina, O.L. et al. Role of Nitric Oxide in the Pathogenesis of Alloxan Diabetes. Bull Exp Biol Med 154, 602–605 (2013). https://doi.org/10.1007/s10517-013-2009-4
Received:
Published:
Issue Date:
DOI: https://doi.org/10.1007/s10517-013-2009-4